Headlands Technologies’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$73.1K Buy
+4,936
New +$73.1K 0.01% 692
2025
Q1
Sell
-4,048
Closed -$70.5K 1529
2024
Q4
$70.5K Sell
4,048
-9,637
-70% -$168K 0.01% 740
2024
Q3
$191K Buy
+13,685
New +$191K 0.02% 536
2024
Q2
Sell
-302
Closed -$2.33K 1615
2024
Q1
$2.33K Sell
302
-2,309
-88% -$17.8K ﹤0.01% 1155
2023
Q4
$23.5K Buy
+2,611
New +$23.5K 0.01% 644